Mini Nutrition Assessment-Short Form score is associated with sarcopenia even among nourished people - A result of a feasibility study of a registry.

Autor: Shadmand Foumani Moghadam MR; Department of Nutrition Science Varastegan Institute for Medical Sciences Mashhad Iran., Shahraki Jazinaki M; Department of Nutrition Science, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran., Rashidipour M; Department of Health and Nutrition Islamic Azad University, Science And Research Branch Tehran Iran., Rezvani R; Department of Nutrition Science, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran., Pezeshki P; Department of Food Science and Technology Varastegan Institute for Medical Sciences Mashhad Iran., Ghayour Mobarhan M; Department of Nutrition Science, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran.; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition Mashhad University of Medical Sciences Mashhad Iran., Hosseini Z; Department of Nutrition Science Varastegan Institute for Medical Sciences Mashhad Iran.
Jazyk: angličtina
Zdroj: Aging medicine (Milton (N.S.W)) [Aging Med (Milton)] 2023 Jun 22; Vol. 6 (3), pp. 264-271. Date of Electronic Publication: 2023 Jun 22 (Print Publication: 2023).
DOI: 10.1002/agm2.12257
Abstrakt: Objectives: This study aims to identify a new barrier to the use of the Mini-Nutrition Assessment Short-Form (MNA-SF), which is a malnutrition assessment tool for the risk assessment of sarcopenia in a nourished population.
Methods: The MNA-SF was completed, and individuals with a score of > 11 were considered nourished in this cross-sectional feasibility study of a registry. Sarcopenia was assessed in 766 healthy, nourished adults (33.4% men, 64.9 ± 7.1 years) based on the European Working Group on Sarcopenia in Older People 2 (EWGSOP2).
Results: The MNA-SF scores for non-sarcopenia, pre-, confirmed, and severe sarcopenia were 13.59 ± 0.69, 13.73 ± 0.60, 12.64 ± 0.74, and 12.5 ± 0.71, respectively. The higher MNA-SF score association with pre-sarcopenia [odds ratio (OR): 1.41, 95% confidence interval (CI): 1.06-1.86, P  = 0.02], confirmed sarcopenia (OR = 0.25, 95% CI: 0.13-0.49, P  < 0.001), and severe sarcopenia (OR = 0.20, 95% CI: 0.09-0.46, P  < 0.001) was as significant as in the MNA-SF categories. Individuals with a score = 13 (compared with 14), had a higher risk of confirmed sarcopenia (OR = 10.07, 95% CI: 1.92-52.71, P  = 006) and severe sarcopenia (OR = 12.09, 95% CI: 1.24-117.50, P  = 0.032). Individuals with a score of 12 had a higher risk of confirmed sarcopenia (OR = 30.94, 95% CI: 4.25-103.02, P  < 0.001) and severe sarcopenia (OR = 35.90, 95% CI: 4.25-303.07, P  = 0.001) compared with subjects with a score of 14. The models also showed that MNA-SF < 13 could predict sarcopenia.
Conclusion: There was a significant association between MNA-SF and confirmed and severe sarcopenia in nourished people. Sarcopenia assessment in people with MNA-SF < 13 can be beneficial. Developing a tool to identify the risk of malnutrition and sarcopenia at the same time based on MNA-SF can be considered.
Competing Interests: There is no conflict of interest to declare.
(© 2023 The Authors. Aging Medicine published by Beijing Hospital and John Wiley & Sons Australia, Ltd.)
Databáze: MEDLINE
Externí odkaz: